Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-31 Purchase | 2023-01-31 10:14 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $4.05 | $81,000 | 5,471,873 (Direct) | View |
| 2023-01-24 Purchase | 2023-01-24 10:49 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $4.19 | $83,800 | 5,451,873 (Direct) | View |
| 2022-11-22 Sale | 2022-11-25 4:41 pm | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 24,500 | $4.233 | $103,708 | 1,060,414 (Direct) | View |
| 2022-11-18 Sale | 2022-11-22 4:15 pm | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 22,261 | $4.3568 | $96,986 | 1,084,914 (Direct) | View |
| 2022-11-08 Purchase | 2022-11-10 4:44 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner | 402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) | View |
| 2022-11-08 Purchase | 2022-11-10 4:38 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) | View |
| 2022-09-28 Purchase | 2022-09-28 4:45 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 10,000 | $2.32 | $23,200 | 5,431,873 (Direct) | View |
| 2022-09-26 Purchase | 2022-09-27 09:47 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.27 | $34,050 | 5,421,873 (Direct) | View |
| 2022-09-07 Purchase | 2022-09-08 10:12 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $3.03 | $45,450 | 5,406,873 (Direct) | View |
| 2022-09-01 Purchase | 2022-09-01 2:37 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.83 | $42,450 | 5,391,873 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-17 4:06 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $3.05 | $45,750 | 5,376,873 (Direct) | View |
| 2022-08-10 Purchase | 2022-08-10 10:51 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.64 | $39,600 | 5,361,873 (Direct) | View |
| 2022-08-01 Purchase | 2022-08-02 09:15 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.58 | $38,700 | 5,346,873 (Direct) | View |
| 2022-06-21 Purchase | 2022-06-21 1:41 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $2.8 | $56,000 | 5,331,873 (Direct) | View |
| 2022-06-16 Purchase | 2022-06-17 4:46 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $2.34 | $46,800 | 5,311,873 (Direct) | View |
| 2022-06-13 Purchase | 2022-06-13 3:59 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 30,000 | $2.29 | $68,700 | 5,291,873 (Direct) | View |
| 2022-06-06 Purchase | 2022-06-07 11:50 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 30,000 | $2.83 | $84,900 | 5,261,873 (Direct) | View |
| 2022-06-01 Purchase | 2022-06-01 12:33 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $3.03 | $60,600 | 5,231,873 (Direct) | View |
| 2022-05-26 Purchase | 2022-05-26 2:58 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $3.04 | $60,800 | 5,211,873 (Direct) | View |
| 2022-05-23 Purchase | 2022-05-24 08:09 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 18,355 | $2.72 | $49,926 | 5,191,873 (Direct) | View |
| 2022-05-17 Purchase | 2022-05-17 3:17 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,215 | $2.47 | $49,931 | 5,173,518 (Direct) | View |
| 2022-05-11 Purchase | 2022-05-13 5:48 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 192,516 | $2.1841 | $420,482 | 18,389,422 (Indirect) | View |
| 2022-05-11 Purchase | 2022-05-13 5:45 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner | 192,516 | $2.1841 | $420,482 | 18,389,422 (Indirect) | View |
| 2022-05-06 Purchase | 2022-05-10 6:21 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner | 125,359 | $1.5735 | $197,252 | 18,196,906 (Indirect) | View |
| 2022-05-06 Purchase | 2022-05-10 6:19 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 125,359 | $1.5735 | $197,252 | 18,196,906 (Indirect) | View |
| 2022-05-10 Purchase | 2022-05-10 2:15 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 27,836 | $1.8 | $50,105 | 5,153,303 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-26 Option Award | 2022-04-28 1:52 pm | N/A 2032-04-25 | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-04-26 Ownership | 2022-04-28 1:50 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 0 | $0 | 0 (Direct) | View |
| 2022-04-26 Option Award | 2022-04-28 1:29 pm | N/A 2032-04-25 | Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-04-26 Ownership | 2022-04-28 1:28 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director | 0 | $0 | 0 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 5:45 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | Ferneau Philip Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 5:45 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 5:45 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | Kaplan Brett Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 5:45 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | SQUINTO STEPHEN P Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-02-18(A) Option Award | 2022-02-23 5:30 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | Kalled Susan Chief Scientific Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-02-18(A) Option Award | 2022-02-23 5:30 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-02-18(A) Option Award | 2022-02-23 5:30 pm | N/A 2032-02-17 | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. Chief Executive Officer | 700,000 | $0 | 700,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-18 7:13 pm | N/A 2032-02-16 | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. Chief Executive Officer | 700,000 | $0 | 700,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-18 7:13 pm | N/A 2032-02-16 | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 500,000 | $0 | 500,000 (Direct) | View |